Protara Therapeutics Inc reports results for the quarter ended in January - Earnings Summary

Protara Therapeutics

02/05/2024 15:42

* Protara Therapeutics Inc  TARA.OQ  reported a quarterly
adjusted
loss of 97 cents​​ per share for the quarter ended in January,
lower than the same quarter last year, when the company reported
EPS of -80 cents.  The mean expectation of four analysts for the
quarter was for a loss of 92 cents per share. Wall Street
expected results to range from $-1.07 to -64 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Protara Therapeutics Inc's reported EPS for the quarter
was a
loss of 97 cents​.
    * The company reported a quarterly loss of $11.1 million.
    * Protara Therapeutics Inc shares had fallen by 26.9% this
quarter and gained 56.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 3.4%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "strong buy"

Wall Street's median 12-month price target for Protara
Therapeutics Inc is $23.00 
This summary was machine generated from LSEG data May 2 at 02:42
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.92          -0.97          Missed
 Dec. 31 2023      -0.92          -0.90          Beat
 Sep. 30 2023      -0.98          -0.87          Beat
 Jun. 30 2023      -0.87          -1.00          Missed